BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25424712)

  • 1. Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett syndrome-like phenotype.
    Williamson SL; Ellaway CJ; Peters GB; Pelka GJ; Tam PP; Christodoulou J
    Eur J Hum Genet; 2015 Sep; 23(9):1171-5. PubMed ID: 25424712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RettBASE: Rett syndrome database update.
    Krishnaraj R; Ho G; Christodoulou J
    Hum Mutat; 2017 Aug; 38(8):922-931. PubMed ID: 28544139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
    Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
    J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
    Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
    Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of the Rett syndrome experimental model mecp2
    Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
    J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RETT SYNDROME CASE WITH NOVEL NON-IDENTICAL MUTATION IN MECP2 GENE.
    Güngör O; Kirik S; Cevizli D; Karaokur F; Ozer L; Uysal S; Dilber C
    Genet Couns; 2015; 26(4):387-92. PubMed ID: 26852508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic Variants in
    Cogliati F; Giorgini V; Masciadri M; Bonati MT; Marchi M; Cracco I; Gentilini D; Peron A; Savini MN; Spaccini L; Scelsa B; Maitz S; Veneselli E; Prato G; Pintaudi M; Moroni I; Vignoli A; Larizza L; Russo S
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Hungarian patients with Rett syndrome phenotype for MECP2, CDKL5 and FOXG1 gene mutations.
    Hadzsiev K; Polgar N; Bene J; Komlosi K; Karteszi J; Hollody K; Kosztolanyi G; Renieri A; Melegh B
    J Hum Genet; 2011 Mar; 56(3):183-7. PubMed ID: 21160487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical variations in a Norwegian sample diagnosed with Rett syndrome.
    Henriksen MW; Breck H; Sejersted Y; Diseth T; von Tetzchner S; Paus B; Skjeldal OH
    Brain Dev; 2020 Aug; 42(7):484-495. PubMed ID: 32336485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
    Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
    Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
    Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
    Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
    Jordan C; Li HH; Kwan HC; Francke U
    BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo deletion in MECP2 in a monozygotic twin pair: a case report.
    Mittal K; Kabra M; Juyal R; BK T
    BMC Med Genet; 2011 Aug; 12():113. PubMed ID: 21871116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual double mutation in MECP2 and CDKL5 genes in Rett-like syndrome: Correlation with phenotype and genes expression.
    Jdila MB; Triki CC; Ghorbel R; Bouchalla W; Ncir SB; Kamoun F; Fakhfakh F
    Clin Chim Acta; 2020 Sep; 508():287-294. PubMed ID: 32445745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome.
    Vidal S; Brandi N; Pacheco P; Maynou J; Fernandez G; Xiol C; Pascual-Alonso A; Pineda M; ; Armstrong J
    Eur J Paediatr Neurol; 2019 Jul; 23(4):609-620. PubMed ID: 31105003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.